0 0 0
Dieser Online-Shop verwendet Cookies für ein optimales Einkaufserlebnis. Dabei werden beispielsweise die Session-Informationen oder die Spracheinstellung auf Ihrem Rechner gespeichert. Ohne Cookies ist der Funktionsumfang des Online-Shops eingeschränkt. Sind Sie damit nicht einverstanden, klicken Sie bitte hier.

Nasir, Coppola Neuroendocrine Tumors: Pathology, Molecular and Therapeutic Advances

A Case Based Review

ISBN: 978-1-4939-3424-9

Auflage: 1st Ed.

Erscheinungsdatum: September 2016

Einband: Hardcover

Seitenzahl: 542 p.

Illustrationen: 270 ill.

Verlag: Springer

Lieferzeit ab Ihrer Bestellung: 2-14 Tage je nach Lieferbarkeit und Verlag

Beschreibung

  • Written by an outstanding team of practicing neuroendocrine pathologists and oncologists
  • Case-based review format provides practical diagnostic and therapeutic approach
  • Focuses on the newer histological grading schemes of the major neuroendocrine societies

This text brings together the diagnostic and clinical expertise of an outstanding team of practicing neuroendocrine pathologists and oncologists. The case-based review format provides a practical diagnostic and therapeutic approach to illustrate real-life examples of a diverse range of neuroendocrine tumors that were diagnosed and worked-up in the multi-disciplinary setting of one of the leading academic cancer centers in the United States. In addition to the clinic-pathologic and molecular advances in the field of neuroendocrine oncology, this book focuses on the newer histological grading schemes by the North American NeuroEndocrine Tumor Society (NANETS), European NeuroEndocrine Tumor Society (ENETS) and the World Health Organization (WHO) and the recently proposed pathologic staging systems by the AJCC, WHO and ENETS. Individual case discussions are integrated with pertinent progress in molecular characterization of these unusual neoplasms. The balanced case content allows the reader to develop a comprehensive and practical understanding of the current trends in the pathology and molecular diagnosis of neuroendocrine neoplasms.